Results 151 to 160 of about 690,294 (320)

An Unusual Etiology of Aortic Insufficiency: A Case Report. [PDF]

Cureus, 2022
Libera R, Oke I, Shah S, Amin S, Mochon A.   +4 more
europepmc   +1 more source

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

ESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang, Umar Raza, Jia Song, Junyan Lu, Shun Yao, Xiaohong Liu, Wei Zhang, Shujuan Li   +7 more
wiley   +1 more source

The dawn of surgical treatment of aortic insufficiency. [PDF]

J Card Surg, 2022
Vendramin I, Bortolotti U, Milano AD, Livi U.   +3 more
europepmc   +1 more source

The study of the relationship between unicuspid aortic valve insufficiency and heart disease by fluid-structure interaction modeling

, 2023
Saied Qashqaie Abdi, Kamran Hassani
openalex   +1 more source

Balloon Expandable Transcatheter Aortic Valve Implantation in Failing Self-Expandable Transcatheter Valve in Degenerated Surgical Bioprosthesis: Valve-in-Valve-in-Valve Implantation for the Treatment of Early Degenerative Prosthetic Insufficiency [PDF]

, 2021
Ahmed Subahi, Rashid Alhusain, Rasikh Ajmal, Chaman Sohal, Ali Omar   +4 more
openalex   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Fluid- and Biomechanical Analysis of Ascending Thoracic Aorta Aneurysm with Concomitant Aortic Insufficiency

Annals of Biomedical Engineering, 2017
F. Condemi, F. Condemi, F. Condemi, Salvatore Campisi, M. Viallon, Thomas Troalen, G. Xuexin, A. Barker, M. Markl, P. Croisille, O. Trabelsi, O. Trabelsi, O. Trabelsi, Cristina Cavinato, Cristina Cavinato, Cristina Cavinato, A. Duprey, Stephane Avril, Stephane Avril, Stephane Avril   +19 more
semanticscholar   +1 more source

Severe aortic insufficiency-induced cardiogenic shock treated with left atrial VA-ECMO and emergent valve-in-valve TAVR. [PDF]

ESC Heart Fail, 2023
Golzarian H, Thiel A, Hempfling G, Otto M, Otto T, Shappell E, Racer L, Martz D, Recker-Herman CM, Laird A, Cole WC, Sirak J, Patel SM.   +12 more
europepmc   +1 more source

A woman ( 30-year-old ) case of Werner's syndrome discovered by cardiac insufficiency with aortic valve stenosis.

, 1996
渡辺 正, 大角 幸男, 長野 俊彦, 藤澤 攻, 和田 啓明, 島田 武, 長井 孝太郎, 高木 昌一, 瀬古 章, 天野 和雄   +9 more
openalex   +2 more sources

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source